LIGAND PHARMACEUTICALS INC — Director's Dealing 2012

Jan 6, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGNDD)
CIK: 0000886163
Period of Report: 2011-12-30

Reporting Person: Berkman Charles S (VP, Gen. Counsel & Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-30	Common Stock	J	1238.0	$10.0895	Acquired	15934.0	Direct

Footnotes

F1: Shares Acquired under Ligand's employee stock purchase plan.